Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2005
11/15/2005US6964197 Shelf life testing unit
11/15/2005US6964187 Vacuum sensor
11/15/2005CA2425761C Non-invasive enzyme screen for tissue remodelling-associated conditions
11/15/2005CA2114440C Differential binding affinities and dissociation assays based thereon
11/14/2005CA2810292A1 Ligand for g-protein coupled receptor fprl2 and uses thereof
11/14/2005CA2504920A1 Ligand for g-protein coupled receptor fprl2 and uses thereof
11/12/2005CA2811046A1 Method and system for reservoir characterization in connection with drilling operations
11/12/2005CA2506991A1 Method and system for reservoir characterization in connection with drilling operations
11/10/2005WO2005106923A2 Identification of modified peptides by mass spectrometry
11/10/2005WO2005106764A2 Method, system and apparatus for assembling and using biological knowledge
11/10/2005WO2005106760A2 Chemical and biological agent sensor array
11/10/2005WO2005106499A2 Method of high throughput screening of anitoxidants at near ambient temperatures
11/10/2005WO2005106498A1 Device and method for detecting the presence of hemoglobin in a biological sample
11/10/2005WO2005106497A2 Led bonding structures and methods of fabricating led bonding structures
11/10/2005WO2005106496A1 Method for protein protection
11/10/2005WO2005106495A1 Procollagen ii biomarkers and methods
11/10/2005WO2005106494A2 Monoclonal antibodies, hybridomas, improved method for determining the protein ptx3 and kit for said determination
11/10/2005WO2005106493A1 Diagnostics and therapeutics for diseases associated with g protein-coupled apelin receptor (apj)
11/10/2005WO2005106492A2 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3)
11/10/2005WO2005106491A2 Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)
11/10/2005WO2005106490A1 Diagnostics and therapeutics for diseases associated with chemokine-like receptor 1 (cmklr1)
11/10/2005WO2005106489A2 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 5 (ccr5)
11/10/2005WO2005106488A2 Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2)
11/10/2005WO2005106487A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 9 (dpp9)
11/10/2005WO2005106486A2 Diagnostic and therapeutics for diseases associated with dipeptidyl-peptidase 3(dpp3)
11/10/2005WO2005106485A1 Agent for predicting and judging the recurrence after treating liver cancer
11/10/2005WO2005106484A1 Diagnostics and therapeutics for diseases associated with melanocortin 1 receptor (mc1r)
11/10/2005WO2005106483A1 Detection of west nile virus
11/10/2005WO2005106482A1 Cultispot assay
11/10/2005WO2005106481A2 Method for identifying a ligand capable of selectively modulating a functional cascade involving a target, and uses thereof for high-throughput screening of molecules of interest
11/10/2005WO2005106480A1 Detector and detecting method
11/10/2005WO2005106479A1 Non-elispot assay
11/10/2005WO2005106478A1 Method for functionalizing biosensor chips
11/10/2005WO2005106477A2 Biomolecule immobilisation using atmospheric plasma technology
11/10/2005WO2005106476A2 Method for diagnosing infectious diseases
11/10/2005WO2005106475A2 Novel method for determination of plasminogen activator inhibitor
11/10/2005WO2005106474A2 Liver disease diagnosis system, method and graphical user interface
11/10/2005WO2005106473A1 Method of screening therapeutic agent for neurodegenerative disease
11/10/2005WO2005106472A1 Biochip producing method, biochip, biochip analyzing device, biochip analyzing method
11/10/2005WO2005106471A2 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 4 (ccr4)
11/10/2005WO2005106470A1 Rapid diagnostic strip comprising a moisture-absorbing material and the blister packaging thereof
11/10/2005WO2005106469A1 Modulation of a human immune response
11/10/2005WO2005106468A2 Clamp-on chamber for flow porometry
11/10/2005WO2005106467A1 Blood coagulation test cartridge, system, and method
11/10/2005WO2005106466A1 Blood coagulation test cartridge, system, and method
11/10/2005WO2005106465A1 High-q lc circuit moisture sensor
11/10/2005WO2005106464A1 Methods of assessing characteristics of fibrous substrates and treating fibrous substrates
11/10/2005WO2005106463A1 Sample analyzing tool
11/10/2005WO2005106462A2 Methods for use of fluorescent nanoparticles to determine free volume and to detect and deliver materials to repair cracks in polymers and polymer composites
11/10/2005WO2005106461A1 Device for determining properties of a concrete paste
11/10/2005WO2005106460A1 Volume-differential assay using hydrophic gel
11/10/2005WO2005106459A1 Method of determining ability of drug to bind to troponin i and test drug for the determination
11/10/2005WO2005106458A2 Methods and systems for analyzing solids
11/10/2005WO2005106457A1 Test kit and method for the determination of nitrogen components in wine
11/10/2005WO2005106454A1 Method and apparatus for detection of live bacterium within test subject antigen through specifically labeling thereof
11/10/2005WO2005106447A1 Method for detection and analysis of macromolecular complexes
11/10/2005WO2005106446A1 Blood sugar level measuring device
11/10/2005WO2005106445A1 Micro-electrode array
11/10/2005WO2005106443A1 Gas-sensor for the determination of isocyanates using metal oxide semiconductors
11/10/2005WO2005106432A1 Optical method and system to determine distribution of lipid particles in a sample
11/10/2005WO2005106427A1 Device and method for sorting biological particles
11/10/2005WO2005106426A1 Measurement of an object
11/10/2005WO2005106425A1 Generation of frequency distribution for objects
11/10/2005WO2005106424A2 Method for testing the resistance to scratching of plastic surfaces
11/10/2005WO2005106047A2 Detection of molecular interactions using colloid dispersion
11/10/2005WO2005106039A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
11/10/2005WO2005106038A2 Neural proteins as biomarkers for nervous system injury and other neural disorders
11/10/2005WO2005106036A2 Methods and compositions for assaying analytes
11/10/2005WO2005106034A1 Method and device for detection of nucleic acids and/or polypeptides
11/10/2005WO2005106030A1 Method of nucleic acid detection
11/10/2005WO2005106029A1 Method of analyzing nucleic acid
11/10/2005WO2005106028A1 Method of identifying target of compound acting on natural immunity
11/10/2005WO2005106021A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 8 (dpp8)
11/10/2005WO2005106019A1 Granulin-epithelin precursor (gep) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (hcc)
11/10/2005WO2005106018A1 Direct assay of skin cholesterol in skin samples removed by tape stripping
11/10/2005WO2005106016A1 METHOD OF DETECTING Th1 CELL
11/10/2005WO2005106015A1 Method of screening remedy for diabetes
11/10/2005WO2005106014A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor adrb1 (adrb1)
11/10/2005WO2005106013A2 Use of mdck cell line to predict corneal penetration of drugs
11/10/2005WO2005106012A2 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (dpp1)
11/10/2005WO2005105998A1 HUMAN ANTIAMYLOID β PEPTIDE ANTIBODY AND ANTIBODY FRAGMENT THEREOF
11/10/2005WO2005105997A1 Connexin 40 tissue specific gene mutations
11/10/2005WO2005105987A1 Diagnostics and therapeutics for diseases associated with casein kinase 1, delta, isoform 2 (csnk1d iso 2)
11/10/2005WO2005105850A1 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same
11/10/2005WO2005105847A2 Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof
11/10/2005WO2005105839A2 Essential tremor diagnostic and treatment
11/10/2005WO2005105838A2 Ion channel
11/10/2005WO2005105830A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment
11/10/2005WO2005105308A1 Functionalized porous supports for microarrays
11/10/2005WO2005105144A1 LATENT TGF-β ACTIVATION INHIBITOR
11/10/2005WO2005105064A2 Modulators of frat-lrp interaction in the treatment of bone-related diseases
11/10/2005WO2005104834A2 Pain-associated gene pnpg5
11/10/2005WO2005104833A1 Method of constructing animal model suffering from left ventricular diastolic disorder for examining heart failure and method of examining remedy for heart failure caused by left ventricular diastolic failure with the use of the animal model
11/10/2005WO2005104785A2 Methods and compositions for specifically targeting human hepatocellular carcinoma cells
11/10/2005WO2005104763A2 Improved method for identifying peptides in a biological sample
11/10/2005WO2005104755A2 Artificial immune system: methods for making and use
11/10/2005WO2005098441A3 Method to detect molecular binding by surface-enhanced raman spectroscopy
11/10/2005WO2005098421A3 Sensor for contaminants
11/10/2005WO2005085860A3 New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
11/10/2005WO2005084210A3 Multiplex detection probes
1 ... 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 ... 3937